On January 16th Beijing time, the Wizards officially confirmed Whitmore’s diagnosis of venous vascular disease and that he has started recovery treatment. He will miss the rest of the 2025-26 season’s games. The team will release further updates when appropriate.


On December 24th last year, the Wizards announced that wing guard Whitmore was diagnosed with deep vein thrombosis in his upper arm and was expected to be sidelined indefinitely. The team will closely monitor his rehabilitation progress and update his playing status accordingly. Last season, Spurs star Wembanyama missed the entire season after being diagnosed with deep vein thrombosis in his right shoulder.
Whitmore has not appeared in any games since December 5th. He was listed as a "coach's decision to sit out" for four consecutive games, then added to the injury report for right shoulder soreness in the following two games. Further examination of the sore shoulder revealed thrombosis symptoms.

After playing one season at Villanova University in 2022-23, Whitmore declared for the draft. Once considered a potential top-five pick in the 2023 draft, he ultimately fell to the 20th pick, selected by the Rockets. During his two seasons in Houston, he mainly came off the bench with limited minutes but showed promising scoring ability—averaging 17.4 minutes per game, 10.8 points, with shooting percentages of 44.9% from the field, 35.7% from three, and 70.7% from the free-throw line.
Deemed not part of the Rockets’ long-term plans, Whitmore was traded to the Wizards during the 2025 offseason in exchange for two second-round draft picks. In 21 games with Washington, he averaged 9.2 points per game, with shooting splits of 45.6%, 28.6%, and 74.2% respectively.

Current NBA players such as Wembanyama, Ingram, and Osar-Thompson have faced similar conditions and all have fully recovered and returned to play.